Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Disc Medicine, Inc.
Market Cap
$2.44B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.45B
Operating Margin
-32.45%
TTM Avg
-449.54%
3Y Avg
-390.50%
5Y Avg
-1635.66%
Market Cap
$2.43B
Operating Margin
-0.74%
TTM Avg
-3.89%
3Y Avg
-12.55%
5Y Avg
-17.88%
Market Cap
$2.36B
Operating Margin
42.26%
TTM Avg
35.06%
3Y Avg
13.24%
5Y Avg
-28.82%
Market Cap
$2.29B
Operating Margin
24.03%
TTM Avg
25.35%
3Y Avg
27.79%
5Y Avg
25.07%
Market Cap
$2.65B
Operating Margin
-867.87%
TTM Avg
-840.98%
3Y Avg
-774.76%
5Y Avg
-1234.34%
Market Cap
$2.23B
Operating Margin
0.41%
TTM Avg
-3.56%
3Y Avg
0.15%
5Y Avg
-1.31%
Market Cap
$2.69B
Operating Margin
10.06%
TTM Avg
14.13%
3Y Avg
15.87%
5Y Avg
13.57%
Market Cap
$2.72B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Disc Medicine, Inc. (IRON) | $2.44B | 0.00% | 0.00% | 0.00% | 0.00% |
| Liquidia Corporation (LQDA)vs › | $2.45B | -32.45% | -449.54% | -390.50% | -1635.66% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | -0.74% | -3.89% | -12.55% | -17.88% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 42.26% | 35.06% | 13.24% | -28.82% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.29B | 24.03% | 25.35% | 27.79% | 25.07% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.65B | -867.87% | -840.98% | -774.76% | -1234.34% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.23B | 0.41% | -3.56% | 0.15% | -1.31% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 10.06% | 14.13% | 15.87% | 13.57% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.72B | -274.57% | -464.41% | -382.79% | -92575.80% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.71B | -42.22% | -21.11% | -21.11% | -21.11% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
